Friday, 16 October 2026European Markets

GEOJUNXION Stock Over 17% Down So Far Today

Loading stream...

GeoJunxion (GOJXN.AS), a distinguished provider of digital maps and location intelligence services, witnessed a significant plunge of 17.8% in its shares during Tuesday trading with the value dropping to EUR0.82. The dip came unexpectedly, particularly given the strong upward momentum seen in the previous trading session as well as a third continuous daily loss experienced by the Netherlands AEX-Index; which suffered a 0.7% loss.

GeoJunxion's Performance Overview

The company, GeoJunxion, which caters to various applications by providing digital maps needed for routing and resource planning, closed its last trading session significantly below its 52-week high of EUR2.10. Regardless, it remained noticeably above its 52-week low of EUR0.95. This clearly indicates that this year's journey has been quite fluctuating for GeoJunxion's stock price,, revealing possibly its instabilities to the investors.

Declining Earnings Per Share (EPS)

Parallel to GeoJunxion's stock decline, its earnings per share (EPS) has also taken a downward spiral. The EPS recorded was EUR-0.2 in the trailing twelve months indicating less or zero profitability. This is further corroborated by an unsubstantial 2.12% return on equity measure, which displays a low level of profitability relative to shareholder equity.

Challenges Ahead?

Despite the challenges, it's worth noting that GeoJunxion has successfully established its foothold in the global digital economy. Its products like location content products and location intelligence services are indispensable to various industries. However, its current financial status and stock trajectory suggest potential challenges. These may revolve around asserting its dominance in its niche market, dealing with economic disarray, or managing its finances more effectively.

Investor's Perspective and Conclusion

Prospective investors looking to add GeoJunxion to their asset class should initially evaluate its current volatility and financial performance indicators. Such a detailed analysis will likely assist them in making informed and major investment decisions.

More news about GEOJUNXION (GOJXN.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com